Medicare Enrolled

Dr. Donald McCarren, DO

Neurology · Bonita Springs, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
28420 BONITA CROSSINGS BLVD UNIT 110, Bonita Springs, FL 34135
2392350380
In practice since 2006 (19 years)
NPI: 1255385662 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. McCarren from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McCarren? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. McCarren

Dr. Donald McCarren is a neurology in Bonita Springs, FL, with 19 years in practice. Based on federal Medicare data, Dr. McCarren performed 100,446 Medicare services across 1,176 unique beneficiaries.

Between the years covered by Open Payments, Dr. McCarren received a total of $47,548 from 78 pharmaceutical and/or device companies across 850 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. McCarren is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 0% volume in FL$ $47,548 industry payments

Medicare Practice Summary

Medicare Utilization ↗
100,446
Medicare services
Top 0% in FL for neurology
1,176
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,287 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Injection, lecanemab-irmb, 1 mg74,628$1$3
Inclisiran injection (Leqvio) for cholesterol19,372$9$31
Injection, aducanumab-avwa, 2 mg2,322$5$30
Denosumab injection (Prolia/Xgeva)2,280$18$43
Administration of chemotherapy into vein, 1 hour or less372$100$395
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour299$16$64
Measurement of brain wave activity (eeg), awake and drowsy221$296$852
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less191$49$202
Office visit, established patient (30-39 min)186$102$374
Assessment of and care planning for patient with impaired thought processing, typically 60 minutes126$205$619
Drug injection, under skin or into muscle94$11$48
New patient office visit (45-59 min)69$132$486
New patient office visit, complex (60-74 min)66$169$641
Office visit, established patient (20-29 min)62$66$280
Administration of chemotherapy into vein, each additional hour42$22$84
Needle measurement of electrical activity in arm or leg muscles, complete study30$78$256
Office visit, established patient, complex (40-54 min)25$140$525
Evaluation of neuropsychological test, first hour23$104$299
Administration of psychological or neuropsychological test by technician, first 30 minutes23$27$78
Nerve conduction, 9-10 studies15$147$543
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.5% high complexity
98.9% medium
0.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$47,548
Total received (2018-2024)
Avg $6,793/year across 7 years
Top 9% in FL for neurology
78
Companies
850
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$19,099 (40.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,598 (34.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$11,852 (24.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$16,030
2023
$9,665
2022
$3,680
2021
$2,008
2020
$1,766
2019
$1,621
2018
$12,778

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$10,865
GENZYME CORPORATION
$8,678
Biogen, Inc.
$6,400
Eisai Inc.
$4,675
EMD Serono, Inc.
$2,178
Corium, LLC
$1,517
UCB, Inc.
$1,356
Teva Pharmaceuticals USA, Inc.
$806
Alnylam Pharmaceuticals Inc.
$699
ABBVIE INC.
$695
Amgen Inc.
$634
Neurocrine Biosciences, Inc.
$536
Acorda Therapeutics, Inc
$489
GE HealthCare
$454
Avanir Pharmaceuticals, Inc.
$435
MDD US Operations, LLC
$431
Genentech USA, Inc.
$416
Janssen Pharmaceuticals, Inc
$402
ARGENX US, INC.
$387
Novartis Pharmaceuticals Corporation
$331
Lundbeck LLC
$324
GE HEALTHCARE
$309
AbbVie Inc.
$262
Allergan Inc.
$256
Alexion Pharmaceuticals, Inc.
$244
Biohaven Pharmaceuticals, Inc.
$242
LivaNova USA, Inc.
$233
Medtronic USA, Inc.
$229
Neurelis, Inc.
$212
Celgene Corporation
$193
Life Molecular Imaging Ltd
$184
Sunovion Pharmaceuticals Inc.
$179
ACADIA Pharmaceuticals Inc
$163
E.R. Squibb & Sons, L.L.C.
$144
Allergan, Inc.
$122
Biohaven Pharmaceutical Holding Company Ltd.
$114
Shire North American Group Inc
$113
PFIZER INC.
$100
Promius Pharma LLC
$95
Otsuka America Pharmaceutical, Inc.
$87
Adamas Pharmaceuticals, Inc.
$73
GRT US Holding, Inc.
$68
Amneal Pharmaceuticals LLC
$68
Mallinckrodt Hospital Products Inc.
$64
Supernus Pharmaceuticals, Inc.
$63
Boston Scientific Corporation
$60
IDORSIA PHARMACEUTICALS US INC
$56
CSL Behring
$56
Merz Pharmaceuticals, LLC
$53
TG THERAPEUTICS, INC.
$52
Ipsen Biopharmaceuticals, Inc
$51
Mitsubishi Tanabe Pharma America, Inc.
$43
Jazz Pharmaceuticals Inc.
$42
Zyla Life Sciences
$41
Upsher-Smith Laboratories LLC
$41
MITSUBISHI TANABE PHARMA AMERICA, INC.
$36
EISAI INC.
$36
Mallinckrodt LLC
$33
Amarin Pharma Inc.
$31
US WorldMeds, LLC
$31
HARMONY BIOSCIENCES LLC
$29
Impax Laboratories, Inc.
$28
Alfasigma USA, Inc.
$27
Neos Therapeutics, LP
$27
Merz North America, Inc.
$27
Averitas Pharma Inc.
$25
Nevro Corp.
$21
SANOFI-AVENTIS U.S. LLC
$19
Takeda Pharmaceuticals U.S.A., Inc.
$19
Zyla Life Sciences, Inc.
$18
Regeneron Healthcare Solutions, Inc.
$18
Assertio Therapeutics, Inc.
$17
Avion Pharmaceuticals
$17
Arbor Pharmaceuticals, Inc.
$16
Mylan Pharmaceuticals Inc.
$14
Merck Sharp & Dohme Corporation
$13
Abbott Laboratories
$12
ASSERTIO THERAPEUTICS, Inc.
$11
Top 3 companies account for 54.6% of total payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aduhelm · Adzenys XR-ODT · Aimovig · Austedo XR · BOTOX · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · BRIUMVI · Briviact · COPAXONE · Cambia · DYSPORT · Dhivy · Dysport · EMGALITY · GILENYA · GOCOVRI · Glatiramer Acetate · Gocovri · Gralise · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · LEQVIO · LYRICA · Leqembi · MAVENCLAD · Mavenclad · NEURACEQ · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Neuromodulation Dspsbls and Accs · Nuedexta · OCREVUS · ONFI · ONPATTRO · ONZETRA Xsail · OXTELLAR XR · Ocrevus · Omnia · Ongentys · PRALUENT · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · QUVIVIQ · Qutenza · RADICAVA · REXULTI · ROTATEQ · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPRAVATO · SPRIX · Soliris · TECFIDERA · TROKENDI XR · TYSABRI · Tysabri · UBRELVY · ULTOMIRIS · VALTOCO · VNS Therapy · VUMERITY · VYEPTI · VYVANSE · VYVGART · VYVGART HYTRULO · Vascepa · Vimpat · WATCHMAN Access System · Wakix · XEOMIN · Xeomin · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA · Zembrace · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (40%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 9% for neurology in FL.

Equivalent to $47 per 100 Medicare services performed
Looking for a neurology in Bonita Springs?
Compare neurologys in the Bonita Springs area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
195
Per 100K population
24.6
County median income
$73,099
Nearest hospital
PHYSICIANS REGIONAL MEDICAL CENTER - PINE RIDGE
7.3 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. McCarren is a mixed practice specialist, with above-average Medicare volume (top 0% in FL), and high industry engagement (consulting-driven, top 9%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. McCarren experienced with injection, lecanemab-irmb, 1 mg?
Based on Medicare claims data, Dr. McCarren performed 74,628 injection, lecanemab-irmb, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. McCarren receive payments from pharmaceutical companies?
Yes. Dr. McCarren received a total of $47,548 from 78 companies across 850 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McCarren's costs compare to other neurologys in Bonita Springs?
Dr. McCarren's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McCarren) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →